Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
about
Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis.Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age.Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.
P2860
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pharmacodynamics of the Novel ...... Caused by Aspergillus flavus.
@en
Pharmacodynamics of the Novel ...... Caused by Aspergillus flavus.
@nl
type
label
Pharmacodynamics of the Novel ...... Caused by Aspergillus flavus.
@en
Pharmacodynamics of the Novel ...... Caused by Aspergillus flavus.
@nl
prefLabel
Pharmacodynamics of the Novel ...... Caused by Aspergillus flavus.
@en
Pharmacodynamics of the Novel ...... Caused by Aspergillus flavus.
@nl
P2093
P2860
P356
P1476
Pharmacodynamics of the Novel ...... s Caused by Aspergillus flavus
@en
P2093
Adam Johnson
Clara E Negri
Joanne Livermore
Julie A Schwartz
Laura McEntee
Ruwanthi Kolamunnage-Dona
Sarah Whalley
V Ramos-Martín
P2860
P304
P356
10.1093/INFDIS/JIX479
P407
P577
2018-03-01T00:00:00Z